Logo image
An Fc Domain Protein-Small Molecule Conjugate as an Enhanced lmmunomodulator
Journal article   Open access   Peer reviewed

An Fc Domain Protein-Small Molecule Conjugate as an Enhanced lmmunomodulator

Meng-Jung Chiang, Marc A. Holbert, Jay H. Kalin, Young-Hoon Ahn, John Giddens, Mohammed N. Amin, Martin S. Taylor, Samuel L. Collins, Yee Chan-Li, Adam Waickman, …
Journal of the American Chemical Society, v 136(9), pp 3370-3373
05 Mar 2014
PMID: 24533830
url
https://doi.org/10.1021/ja5006674View
Published, Version of Record (VoR) Open

Abstract

Chemistry Chemistry, Multidisciplinary Physical Sciences Science & Technology
Proteins as well as small molecules have demonstrated success as therapeutic agents, but their pharmacologic properties sometimes fall short against particular drug targets. Although the adenosine 2a receptor (A(2A)R) has been identified as a promising target for immunotherapy, small molecule A(2A)R agonists have suffered from short pharmacokinetic half-lives and the potential for toxicity by modulating nonimmune pathways. To overcome these limitations, we have tethered the AR agonist CGS-21680 to the immunoglobulin Fc domain using expressed protein ligation with Sf9 cell secreted protein. The protein small molecule conjugate Fc-CGS retained potent Fc receptor and A(2A)R interactions and showed superior properties as a therapeutic for the treatment of a mouse model of autoimmune pneumonitis. This approach may provide a general strategy for optimizing small molecule therapeutics.

Metrics

15 Record Views
16 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Chemistry, Multidisciplinary
Logo image